The synergistic oncogenic network formed by ZKSCAN3 with EGFR in ovarian cancer reveals a unique mechanism for remodeling the microenvironment through receptor tyrosine kinase signaling in solid tumors, and its functional studies in multiple myeloma further broaden its scope of action. Here, ZKSCAN3 is linked to ovarian cancer.